Australian Clinical Labs Ltd
ASX:ACL

Watchlist Manager
Australian Clinical Labs Ltd Logo
Australian Clinical Labs Ltd
ASX:ACL
Watchlist
Price: 3.5 AUD -0.28% Market Closed
Market Cap: 700.8m AUD
Have any thoughts about
Australian Clinical Labs Ltd?
Write Note
Section:
 

Relative Value

The Relative Value of one ACL stock under the Base Case scenario is 6.62 AUD. Compared to the current market price of 3.5 AUD, Australian Clinical Labs Ltd is Undervalued by 47%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ACL Relative Value
Base Case
6.62 AUD
Undervaluation 47%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1
P/S
P/S
Price to Sales
1
vs History
22
vs Industry
73
Median 3Y
0.9
Median 5Y
0.9
Industry
2.3
Forward
0.9
More Details
29.3
P/E
P/E
Price to Earnings
29.3
vs History
13
vs Industry
17
Median 3Y
12.8
Median 5Y
12.6
Industry
23.2
Forward
18
More Details
4.4
P/OCF
P/OCF
Price to OCF
4.4
vs History
18
vs Industry
50
Median 3Y
3.9
Median 5Y
3.9
Industry
14.3
More Details
17.5
P/FCFE
P/FCFE
Price to FCFE
17.5
vs History
2
vs Industry
35
Median 3Y
8.4
Median 5Y
8
Industry
20.1
More Details
3.9
P/B
P/B
Price to Book Value
3.9
vs History
27
vs Industry
29
Median 3Y
3.6
Median 5Y
3.6
Industry
2.2
More Details
1.3
EV/S
EV/S
Enterprise Value to Sales
1.3
vs History
15
vs Industry
67
Median 3Y
1.1
Median 5Y
1.1
Industry
2.4
Forward
1.2
More Details
1.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
1.5
vs History
18
vs Industry
77
Median 3Y
1.4
Median 5Y
1.4
Industry
5
More Details
15.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
15.2
vs History
9
vs Industry
22
Median 3Y
7.6
Median 5Y
7.5
Industry
12.8
Forward
4.3
More Details
15.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
15.2
vs History
9
vs Industry
28
Median 3Y
7.6
Median 5Y
7.5
Industry
17.2
Forward
12.4
More Details
5.5
EV/OCF
EV/OCF
Enterprise Value to OCF
5.5
vs History
15
vs Industry
48
Median 3Y
4.9
Median 5Y
5
Industry
14
More Details
5.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
5.7
vs History
25
vs Industry
40
Median 3Y
5.3
Median 5Y
5.3
Industry
18.2
More Details
1.7
EV/IC
EV/IC
Enterprise Value to IC
1.7
vs History
36
vs Industry
50
Median 3Y
1.7
Median 5Y
1.7
Industry
1.9
More Details

Multiples Across Competitors

ACL Competitors Multiples
Australian Clinical Labs Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Australian Clinical Labs Ltd
ASX:ACL
700.8m AUD 1 29.3 15.2 15.2
US
Cigna Group
XMUN:CGN
75.6B EUR 0.3 25.9 8.1 10.4
US
Cigna Corp
NYSE:CI
77.9B USD 0.3 25.6 8 10.3
US
CVS Health Corp
NYSE:CVS
56B USD 0.2 11.2 9.6 9.6
DE
Fresenius Medical Care AG
XMUN:FME
26B EUR 1.3 49 11.2 25.9
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.8B EUR 0.9 -49.2 9.3 19
US
Laboratory Corporation of America Holdings
NYSE:LH
19.3B USD 1.5 44.3 13.2 20.4
US
R1 RCM Inc
NASDAQ:RCM
16.9B USD 6.9 -275.9 36.7 94.9
US
Quest Diagnostics Inc
NYSE:DGX
17.1B USD 1.8 20.4 12.3 16.6
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
13B EUR 0.7 24.5 7.1 16.4
US
DaVita Inc
NYSE:DVA
12.7B USD 1 15.4 8 11.1

See Also

Summary
ACL intrinsic value, competitors valuation, and company profile.
DCF Valuation
ACL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ACL stock valuation using valuation multiples.
Wall Street Estimates
ACL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ACL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.